North American Market Forecast
By 2036, North America region is expected to account for around 45% alpha-2 receptor agonists market share. This growth can be impelled by the growing number of people suffering from attention-deficit/hyperactivity disorder (ADHD). In the United States, nearly 8.7 million adults in the United States are dealing with this disorder. Around 60% of children with ADHD in the US also have at least one other mental, emotional, or behavioral condition, such as depression or anxiety. In addition, an estimated 77% of children diagnosed with ADHD in the United States receive treatment.
APAC Market Statistics
The market in Asia Pacific is predicted to garner significant revenue share during forecast period. The incidence of hypertension-related disorders is on the rise and is a growing concern in the Asian region. The use of alpha-2 receptor agonists is becoming increasingly common, as the prevalence of hypertension in urban adult populations of Asia has been found to vary between 15-35%, as per new criteria (140/90 mm Hg).
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?